相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing of drugs as STAT3 inhibitors for cancer therapy
Pathum S. Thilakasiri et al.
SEMINARS IN CANCER BIOLOGY (2021)
Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors
Christine Brotherton-Pleiss et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase
Ting Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Design and synthesis of 2-Substituted-4-benzyl-5-methylimidazoles as new potential Anti-breast cancer agents to inhibit oncogenic STAT3 functions
Botros Y. Beshay et al.
BIOORGANIC CHEMISTRY (2021)
Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-KB and STAT3 inhibitors
Binglin Zeng et al.
BIOORGANIC CHEMISTRY (2021)
Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide
Xuebao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer
Yuhao Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
Jinyun Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Occurrence, Bioavailability, Anti-inflammatory, and Anticancer Effects of Pterostilbene
Wei-Sheng Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)
Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3
Rizhen Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction
Soo Kyung Park et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancer
Mingming Wei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy
Kai-Rui Feng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains
Gregory La Sala et al.
NATURE COMMUNICATIONS (2020)
Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition
Na Li et al.
BIOORGANIC CHEMISTRY (2020)
2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3/STAT5a inhibitors
Phoebe F. Lamie et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities
Marwa Ali A. Fathi et al.
BIOORGANIC CHEMISTRY (2019)
Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors
Guiping Cai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage
Silei Bi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Unexpected implications of STAT3 acetylation revealed by genetic encoding of acetyl-lysine
Yael Belo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
Design, Synthesis, And Evaluation Of Cyanopyridines As Anti-Colorectal Cancer Agents Via Inhibiting STAT3 Pathway
Lingyuan Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors
Jianpeng Guo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway
Wei Wen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses
Min Huang et al.
NUCLEIC ACIDS RESEARCH (2018)
Linker Variation and Structure-Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors
Francisco Lopez-Tapia et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Synthesis, Biological Evaluation of Fluorescent 23-Hydroxybetulinic Acid Probes, and Their Cellular Localization Studies
Hong Yao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules
Wenda Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
3′-Hydroxypterostilbene Suppresses Colitis-Associated Tumorigenesis by Inhibition of IL-6/STAT3 Signaling in Mice
Ching-Shu Lai et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking
Wenying Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation
Liang Lu et al.
CELL DEATH & DISEASE (2017)
A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells
Ke-Jia Wu et al.
PLOS ONE (2017)
Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy
Wenda Zhang et al.
SCIENTIFIC REPORTS (2017)
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells
Christian Lis et al.
SCIENTIFIC REPORTS (2017)
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway
Ying Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor
Joleen M. Hubbard et al.
DRUGS (2017)
Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo
Peibin Yue et al.
CANCER RESEARCH (2016)
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach
Giulio Poli et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein
Shanshan Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Preclinical Characterization of 3β-(N-Acetyl L-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
Zilma Escobar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors
Philias Daka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Identification of small molecule inhibitors of the STAT3 signaling pathway: Insights into their structural features and mode of action
Kyeojin Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities
Xu Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Evolutions in fragment-based drug design: the deconstruction-reconstruction approach
Haijun Chen et al.
DRUG DISCOVERY TODAY (2015)
Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors
Jean-Rene Pallandre et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma
Gabriella Miklossy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling
Mei-Jung Lai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening
Ka-Ho Leung et al.
METHODS (2015)
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Youzhi Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
New biaryl-chalcone derivatives of pregnenolone via Suzuki-Miyaura cross-coupling reaction. Synthesis, CYP17 hydroxylase inhibition activity, QSAR, and molecular docking study
Najim A. Al-Masoudi et al.
STEROIDS (2015)
Novel 2-Carbonylbenzo[b]thiophene 1,1-Dioxide Derivatives as Potent Inhibitors of STAT3 Signaling Pathway
Peng Ji et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
A Novel Small Molecular STAT3 Inhibitor, LY5, Inhibits Cell Viability, Cell Migration, and Angiogenesis in Medulloblastoma Cells
Hui Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mechanisms of Jak/STAT Signaling in Immunity and Disease
Alejandro V. Villarino et al.
JOURNAL OF IMMUNOLOGY (2015)
A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion
Wei Huang et al.
ACS CHEMICAL BIOLOGY (2014)
Antagonizing STAT3 Dimerization with a Rhodium(III) Complex
Dik-Lung Ma et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)
Haijun Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein-Tyrosine Phosphatase PTPN6
Shujie Hou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Ailian Xiong et al.
CANCERS (2014)
Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy
Haijun Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
An Update on Antitumor Activity of Naturally Occurring Chalcones
En-Hui Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma
Brent D. G. Page et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Analysis of Safety from a Human Clinical Trial with Pterostilbene
Daniel M. Riche et al.
JOURNAL OF TOXICOLOGY (2013)
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Xiaolei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Design, synthesis and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein
Vijay M. Shahani et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
Brent D. G. Page et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells
Aiguo Liu et al.
CANCER SCIENCE (2011)
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
Kuen-Feng Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors
Arun K. Mankan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)
Huameng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies
Vijay M. Shahini et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
Li Lin et al.
MOLECULAR CANCER (2010)
5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization
Santosh K. Sandur et al.
MOLECULAR CANCER RESEARCH (2010)
Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
Fan Yang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
Jianyong Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
Xiaomei Ren et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells
Li Lin et al.
NEOPLASIA (2010)
Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
Dae-Seop Shin et al.
CANCER RESEARCH (2009)
Sorafenib Inhibits Signal Transducer and Activator of Transcription-3 Signaling in Cholangiocarcinoma Cells by Activating the Phosphatase Shatterproof 2
Boris R. A. Blechacz et al.
HEPATOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Curcumin: From ancient medicine to current clinical trials
H. Hatcher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophile
Yen-Chin Liu et al.
LIFE SCIENCES (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Molecular targets of dietary agents for prevention and therapy of cancer
BB Aggarwal et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Stem-like cells in bone sarcomas: Implications for tumorigenesis
CP Gibbs et al.
NEOPLASIA (2005)
Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation
DL Hevehan et al.
BLOOD (2002)
The Stat family in cytokine signaling
JN Ihle
CURRENT OPINION IN CELL BIOLOGY (2001)
分享论文
